Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Future Virology|September 20, 2011
At a crossroads: human DNA tumor viruses and the host DNA damage responsePavel A Nikitin, Micah A Luftig
Microbiology and Molecular Biology Reviews : MMBR|January 16, 2025
Multiple sclerosis and infection: history, EBV, and the search for mechanismElliott D SoRelle, Micah A Luftig
Current Opinion in Virology|November 26, 2019
Reprogramming of cellular metabolic pathways by human oncogenic virusesJohn G Purdy, Micah A Luftig
F1000Research|April 15, 2017
Recent advances in understanding Epstein-Barr virusBrent A Stanfield, Micah A Luftig
Journal of Virology|November 10, 2017
c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell InfectionAlexander M Price, Joshua E Messinger, Micah A Luftig
Current Topics in Microbiology and Immunology|December 2, 2025
EBNA2 and EBNA-LP: The Earliest Viral Latency ProteinsJana M Cable, Jenna C Grabowski, Micah A Luftig
Biorxiv : the Preprint Server for Biology|November 24, 2025
Single-Cell Profiling of HDAC Inhibitor-Induced EBV Lytic Heterogeneity Defines Abortive and Refractory States in B LymphoblastsLauren E Haynes, Ashley P Barry, Micah A Luftig
Plos Pathogens|March 23, 2026
Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblastsLauren E Haynes, Ashley P Barry, Micah A Luftig
Virology|September 27, 2017
The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cisBrigid Chiyoko Poling, Alexander M Price, Micah A Luftig, et al.
Viruses|May 27, 2026
Epstein-Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic ConsiderationsDanielle N Burner, Giselle Y López, Justin T Low, et al.
Pageof 7